Market Research Logo
Region: Africa
Category: Pharmaceuticals

Africa Pharmaceuticals

(303 reports matching your criteria)
  • Analgesics in Algeria

    ... this option is not always appropriate, as they are at greater risk of adverse reactions and side effects, such as being exposed to the risk of acute liver failure due to unintended chronic overdoses. Patients ... Read More

  • Cough, Cold and Allergy (Hay Fever) Remedies in Algeria

    ... from climate change and pollution in Algeria. The category is also expected to continue benefiting from rising urbanisation and greater consumer awareness for certain medicines. These two trends are set to ensure that increasing numbers ... Read More

  • Dermatologicals in Algeria

    ... impact categories perceived more as cosmetics such as hair loss treatments and medicated shampoos. In this light, hair loss treatments and medicated shampoos are expected to remain the best performing categories in dermatologicals over the ... Read More

  • Digestive Remedies in Algeria

    ... production should also help to avoid supply shortages and cover consumer demand without the requirement for high-priced imports. Furthermore, higher levels of education about the importance of various consumer health products in large cities across ... Read More

  • Consumer Health in Algeria

    ... was due to lower import volumes during 2016 and 2017 as a result of growing restrictions on imports. The Ministry of Health decided to ban all products which have similar generics manufactured domestically, despite domestic ... Read More

  • Ethiopia Pharmaceuticals and Healthcare Report Q4 2017

    ... Ethiopia remains a long way from achieving sustainable medicine production. Greaterinterest from foreign investors and further government support will boost the capacity of Ethiopia'spharmaceutical landscape over the long term; however, opportunities for patented firms will ... Read More

  • Herbal/Traditional Products in Algeria

    ... and regular magazine articles and radio programmes are exposing the benefits of the products on offer, which has supported the category’s growth. Additionally, the category is also expected to be supported by the greater demand ... Read More

  • Botswana Pharmaceuticals and Healthcare Report Q4 2017

    ... committed to improving healthcare infrastructure in the country and to tackling the nation's high communicable disease burden, particularly HIV/AIDS. However, the country's small market size will dampen multinational interest, with drugmakers choosing South Africa as ... Read More

  • Sudan Pharmaceuticals and Healthcare Report Q4 2017

    ... economy, a combination of high inflation, poor consumer spending and political fragilities will undermine the pace of pharmaceutical market growth. The government's plans to improve domestic pharmaceutical manufacturer capabilities will attempt to reduce ongoing medicine ... Read More

  • Tanzania Pharmaceuticals and Healthcare Report Q4 2017

    ... tabled before the end of the year. A rapidly rising low-income population of over 55 million coupled with a high disease burden will drive demand for low-cost generic medicines. We expect Tanzania's small pharmaceutical sector ... Read More

  • Mauritius Pharmaceuticals and Healthcare Report Q4 2017

    ... well as the rising demand for chronic disease treatment, will underpin market growth. Meanwhile, new tax incentives for drug manufacturers and the government's active support for the sector's development will encourage drug production as well ... Read More

  • Uganda Pharmaceuticals and Healthcare Report Q4 2017

    ... of the country's public health spending suggests a weak outlook for public healthcare sector provision. Strong private consumption growth will drive medicine spending, with opportunities being presented for multinationals selling high-value patented drugs. Headline Expenditure ... Read More

  • Kenya Pharmaceuticals and Healthcare Report Q4 2017

    ... and increasing chronic disease burden. Strict controls of illegal drug dealings will have asignificant impact on drugs sales within the country. Though it does not yet cover the majority of thecountry's population, the innovative measures ... Read More

  • Zimbabwe Pharmaceuticals and Healthcare Report Q4 2017

    ... pharmaceutical firms to invest locally. As such, we expect theZimbabwean government to prioritise the local generic drug industry in order to control costs and boostdomestic drugmaker competitiveness. Besides encouraging greater investment into local drugmanufacturing, the ... Read More

  • Ghana Pharmaceuticals and Healthcare Report Q4 2017

    ... investment is marred by theelevated industry-specific risks. In particular, the country's stable economic and political regime bode wellfor investment over the coming years, yet the small pharmaceutical market size will ensure this is focussedwithin the ... Read More

  • East African Pharmaceutical Market, Forecast to 2021

    ... highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities for growth in the pharmaceutical sector. While control and eradication of communicable ... Read More

  • Morocco Pharmaceuticals and Healthcare Report Q4 2017

    ... of healthcare infrastructure inthe country. The acknowledgment of shortcomings regarding healthcare coverage and medicine, along withthe government's plans to address such issues, is reassuring, highlighting that the country remainscommitted to increasing access to medicines and ... Read More

  • Gabon Pharmaceuticals and Healthcare Report Q4 2017

    ... balance much like its Sub-Saharan African neighbours. While we expect to see government incentivesthat will encourage the local production of pharmaceuticals to be put in place, medicine shortages willpersist, especially in rural areas. Headline Expenditure ... Read More

  • Namibia Pharmaceuticals and Healthcare Report Q4 2017

    ... small pharmaceuticalmarket and below-average per capita spending on medicines lower the country's competitiveness in theSouthern Africa region. These factors continue to act as a deterrent to multinational pharmaceuticalcompany investment in the local production of medicines. ... Read More

  • Mozambique Pharmaceuticals and Healthcare Report Q4 2017

    ... the country's underdevelopedpharmaceutical and healthcare sectors. The country's high prevalence of diseases coupled with a risingpopulation should support market growth over the coming years, although this will be almost exclusively inthe generic drug segment due ... Read More

  • Nigeria Pharmaceuticals and Healthcare Report Q4 2017

    ... will continue to be challenged by the slow progress of government reforms in thewider economy, we expect company growth will return over the long-term as economic growth picks up. Headline Expenditure Forecast Pharmaceuticals: NGN185.7bn (USD719mn) ... Read More

  • Cameroon Pharmaceuticals and Healthcare Report Q4 2017

    ... Africa region. That said, low spending per capita onmedicine and an underdeveloped healthcare system will continue to weigh on the sector's potential. We alsohighlight that political risks derived from the 2018 presidential election have the ... Read More

  • Algeria Pharmaceuticals and Healthcare Report Q4 2017

    ... diseases, will continue to operateas a draw for innovative drugmakers. Despite economic deceleration, the government will continue toprioritise its long-term goal of becoming a global drug manufacturing hub, providing incentives toinvestment. In fact, drug import ... Read More

  • Angola Pharmaceuticals and Healthcare Report Q4 2017

    ... for drugs once they are completed. However, a weak regulatoryframework, a lack of IP legislation and the absence of state reimbursement schemes for anything but themost basic of drugs will mean Angola remains one of ... Read More

  • Penicillin and Streptomycin Markets in Africa to 2021 - Market Size, Development, and Forecasts

    ... most up-to-date market data on the actual market situation, and future outlook for penicillins and streptomycins in different African countries. The package includes penicillin and streptomycin country reports from the following countries: Egypt, Ethiopia, Ghana, ... Read More

1 2 4 6 7 8 9 10